Alvotech is a biopharmaceutical company focused on the creation of biosimilar medicines. It is engaged in the development and manufacture of biosimilar monoclonal antibodies for the treatment of cancer, autoimmune, inflammatory, and other diseases. In addition, the company provides contract cell line research and development, manufacturing, analytical, as well as clinical and regulatory services.